Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Colossus Minerals Inc (EM) COLUF

Consumer Cyclical Healthcare Metals & Mining Biotechnology Industrial Metals & Minerals
Colossus Minerals Inc., a development stage company, engages in the acquisition, exploration, and development of mineral properties. The company primarily holds a 75% interest in the Serra Pelada Mine, a gold-platinum-palladium project that covers an area of approximately 100 hectares and is located in Pará, Brazil. Colossus Minerals Inc. was founded in 2006 and is headquartered in Toronto... see more

Recent & Breaking News (EXPM:COLUF)

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - BCEL, CTLT, NS, SCX

PR Newswire April 17, 2024

BCEL Stock Alert: Halper Sadeh LLC Is Investigating Atreca, Inc.

Business Wire December 26, 2023

Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome

GlobeNewswire December 26, 2023

Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives

GlobeNewswire November 14, 2023

Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross

GlobeNewswire September 21, 2023

Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring

GlobeNewswire August 10, 2023

Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting

GlobeNewswire June 5, 2023

Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments

GlobeNewswire May 10, 2023

Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual Meeting

GlobeNewswire April 26, 2023

Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

GlobeNewswire April 13, 2023

Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data Update

GlobeNewswire March 29, 2023

Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023

GlobeNewswire March 23, 2023

Atreca to Participate at Cowen's 43rd Annual Health Care Conference

GlobeNewswire March 1, 2023

Atreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor Target

GlobeNewswire February 6, 2023

Atreca Appoints Philippe Bishop, MD as Chief Medical Officer

GlobeNewswire January 9, 2023

Atreca Reports Third Quarter 2022 Financial Results and Provides Pipeline Update

GlobeNewswire November 10, 2022

Atreca to Present at Upcoming Investor Conferences

GlobeNewswire November 7, 2022

Atreca Announces Poster Presentations at Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire October 5, 2022

Atreca to Present at Upcoming Investor Conferences

GlobeNewswire September 9, 2022

Atreca Reports Second Quarter 2022 Financial Results and Recent Corporate Developments

GlobeNewswire August 8, 2022

Podcasts